Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Mol Cancer Ther. 2020 Mar 10;19(5):1148–1156. doi: 10.1158/1535-7163.MCT-19-1117

Figure 1.

Figure 1

Waterfall plot of the 30 patients evaluable for tumor response by RECIST 1.1, depicting the best change in overall tumor dimensions. Six patients had a PR as the best response, and 22 had SD.